Michael R. Hayden - 21 Jun 2024 Form 4 Insider Report for AbCellera Biologics Inc. (ABCL)

Role
Director
Signature
Tryn Stimart, attorney-in-fact
Issuer symbol
ABCL
Transactions as of
21 Jun 2024
Net transactions value
$0
Form type
4
Filing time
24 Jun 2024, 18:30:36 UTC
Previous filing
05 Feb 2024
Next filing
03 Jul 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABCL Share option (right to buy) Award $0 +163,934 +33% $0.000000 660,979 21 Jun 2024 Common Shares 163,934 $2.94 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.